MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $207,757 | +6.8% | 778 | -7.5% | 0.01% | 0.0% |
| Q4 2023 | $194,591 | +69.7% | 841 | +7.1% | 0.01% | +50.0% |
| Q3 2023 | $114,641 | -33.3% | 785 | +5.5% | 0.01% | -25.0% |
| Q2 2023 | $171,864 | +4.2% | 744 | +9.3% | 0.01% | 0.0% |
| Q1 2023 | $164,979 | -25.4% | 681 | -10.6% | 0.01% | -20.0% |
| Q4 2022 | $221,171 | +346.6% | 762 | 0.0% | 0.01% | +400.0% |
| Q3 2022 | $49,522 | -9.2% | 762 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $54,544 | -27.0% | 762 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $74,767 | -72.7% | 762 | -76.4% | 0.00% | -25.0% |
| Q4 2021 | $273,710 | +6.2% | 3,230 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $257,722 | -18.1% | 3,230 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $314,634 | +5.9% | 3,230 | +27.2% | 0.00% | 0.0% |
| Q1 2021 | $297,104 | +0.2% | 2,540 | -4.8% | 0.00% | 0.0% |
| Q4 2020 | $296,602 | -6.4% | 2,668 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $316,772 | +4.8% | 2,668 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $302,151 | +69.6% | 2,668 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $178,116 | -26.7% | 2,668 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $243,081 | +5.7% | 2,668 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $230,035 | -6.6% | 2,668 | +13.6% | 0.00% | 0.0% |
| Q2 2019 | $246,199 | -13.1% | 2,349 | +3.8% | 0.00% | -20.0% |
| Q1 2019 | $283,338 | +11.1% | 2,262 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $254,973 | -47.4% | 2,262 | 0.0% | 0.01% | -44.4% |
| Q3 2018 | $484,362 | -99.9% | 2,262 | +17.3% | 0.01% | 0.0% |
| Q2 2018 | $539,522,000 | +218.8% | 1,929 | +33.1% | 0.01% | +350.0% |
| Q1 2018 | $169,229,000 | +127139.8% | 1,449 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $133,000 | – | 1,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |